Correlation Between New Momentum and Ono Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both New Momentum and Ono Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining New Momentum and Ono Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between New Momentum and Ono Pharmaceutical Co, you can compare the effects of market volatilities on New Momentum and Ono Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in New Momentum with a short position of Ono Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of New Momentum and Ono Pharmaceutical.

Diversification Opportunities for New Momentum and Ono Pharmaceutical

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between New and Ono is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding New Momentum and Ono Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ono Pharmaceutical and New Momentum is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on New Momentum are associated (or correlated) with Ono Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ono Pharmaceutical has no effect on the direction of New Momentum i.e., New Momentum and Ono Pharmaceutical go up and down completely randomly.

Pair Corralation between New Momentum and Ono Pharmaceutical

Given the investment horizon of 90 days New Momentum is expected to generate 5.99 times more return on investment than Ono Pharmaceutical. However, New Momentum is 5.99 times more volatile than Ono Pharmaceutical Co. It trades about 0.13 of its potential returns per unit of risk. Ono Pharmaceutical Co is currently generating about -0.22 per unit of risk. If you would invest  0.05  in New Momentum on August 31, 2024 and sell it today you would earn a total of  0.01  from holding New Momentum or generate 20.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

New Momentum  vs.  Ono Pharmaceutical Co

 Performance 
       Timeline  
New Momentum 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days New Momentum has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, New Momentum is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Ono Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ono Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

New Momentum and Ono Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with New Momentum and Ono Pharmaceutical

The main advantage of trading using opposite New Momentum and Ono Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if New Momentum position performs unexpectedly, Ono Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ono Pharmaceutical will offset losses from the drop in Ono Pharmaceutical's long position.
The idea behind New Momentum and Ono Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Correlations
Find global opportunities by holding instruments from different markets